{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:09:56Z","timestamp":1790820596502,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T00:00:00Z","timestamp":1293667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s10096-010-1128-3","type":"journal-article","created":{"date-parts":[[2010,12,29]],"date-time":"2010-12-29T08:01:53Z","timestamp":1293609713000},"page":"603-610","source":"Crossref","is-referenced-by-count":104,"title":["Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-na\u00efve patient\u2014a review of the literature"],"prefix":"10.1007","volume":"30","author":[{"given":"S. J.","family":"van Hal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. B.","family":"Gosbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,30]]},"reference":[{"issue":"12","key":"1128_CR1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","volume":"38","author":"RD Arbeit","year":"2004","unstructured":"Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI (2004) The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38(12):1673\u20131681","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1128_CR2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355(7):653\u2013665","journal-title":"N Engl J Med"},{"issue":"8","key":"1128_CR3","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","volume":"47","author":"JA Silverman","year":"2003","unstructured":"Silverman JA, Perlmutter NG, Shapiro HM (2003) Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47(8):2538\u20132544","journal-title":"Antimicrob Agents Chemother"},{"key":"1128_CR4","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20, vol. 30, no. 1. CLSI, Wayne, Pennsylvania 19087-1898 USA"},{"key":"1128_CR5","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2010) Clinical breakpoints - bacteria (version 1.1). Available online at: http:\/\/www.eucast.org\/clinical_breakpoints . Accessed November 2010"},{"issue":"6","key":"1128_CR6","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.01682-08","volume":"53","author":"NN Mishra","year":"2009","unstructured":"Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS (2009) Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53(6):2312\u20132318","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1128_CR7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","volume":"50","author":"L Friedman","year":"2006","unstructured":"Friedman L, Alder JD, Silverman JA (2006) Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50(6):2137\u20132145","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1128_CR8","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","volume":"42","author":"JB Patel","year":"2006","unstructured":"Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC (2006) An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis 42(11):1652\u20131653","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1128_CR9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","volume":"50","author":"L Cui","year":"2006","unstructured":"Cui L, Tominaga E, Neoh HM, Hiramatsu K (2006) Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 50(3):1079\u20131082","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 3","key":"1128_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1099\/jmm.0.006486-0","volume":"58","author":"A Kirby","year":"2009","unstructured":"Kirby A, Mohandas K, Broughton C, Neal TJ, Smith GW, Pai P, Nistal de Paz C (2009) In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis. J Med Microbiol 58(Pt 3):376\u2013380","journal-title":"J Med Microbiol"},{"issue":"9","key":"1128_CR11","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00533-10","volume":"54","author":"CH Lee","year":"2010","unstructured":"Lee CH, Wang MC, Huang IW, Chen FJ, Lauderdale TL (2010) Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment. Antimicrob Agents Chemother 54(9):4038\u20134040","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1128_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jac\/dkl256","volume":"58","author":"PG Mariani","year":"2006","unstructured":"Mariani PG, Sader HS, Jones RN (2006) Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J Antimicrob Chemother 58(2):481\u2013483","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1128_CR13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ijantimicag.2008.12.010","volume":"33","author":"FC Tenover","year":"2009","unstructured":"Tenover FC, Sinner SW, Segal RE, Huang V, Alexandre SS, McGowan JE Jr, Weinstein MP (2009) Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. Int J Antimicrob Agents 33(6):564\u2013568","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"1128_CR14","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/AAC.00122-10","volume":"54","author":"SJ Yang","year":"2010","unstructured":"Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS (2010) Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob Agents Chemother 54(8):3079\u20133085","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1128_CR15","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","volume":"43","author":"MK Hayden","year":"2005","unstructured":"Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA (2005) Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43(10):5285\u20135287","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1128_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.00660-07","volume":"46","author":"G Sakoulas","year":"2008","unstructured":"Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC Jr, Eliopoulos GM (2008) Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin. J Clin Microbiol 46(1):220\u2013224","journal-title":"J Clin Microbiol"},{"issue":"12","key":"1128_CR17","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","volume":"54","author":"L Cui","year":"2010","unstructured":"Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K (2010) An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 54(12):5222\u20135233","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"1128_CR18","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1128\/AAC.48.12.4665-4672.2004","volume":"48","author":"KL LaPlante","year":"2004","unstructured":"LaPlante KL, Rybak MJ (2004) Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 48(12):4665\u20134672","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1128_CR19","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/AAC.45.6.1799-1802.2001","volume":"45","author":"JA Silverman","year":"2001","unstructured":"Silverman JA, Oliver N, Andrew T, Li T (2001) Resistance studies with daptomycin. Antimicrob Agents Chemother 45(6):1799\u20131802","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1128_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10096-007-0455-5","volume":"27","author":"M Sharma","year":"2008","unstructured":"Sharma M, Riederer K, Chase P, Khatib R (2008) High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 27(6):433\u2013437","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"1128_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","volume":"9","author":"PA Moise","year":"2009","unstructured":"Moise PA, North D, Steenbergen JN, Sakoulas G (2009) Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 9(10):617\u2013624","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1128_CR22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkh191","volume":"53","author":"ES Darley","year":"2004","unstructured":"Darley ES, MacGowan AP (2004) Antibiotic treatment of gram-positive bone and joint infections. J Antimicrob Chemother 53(6):928\u2013935","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1128_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","volume":"48","author":"CB Landersdorfer","year":"2009","unstructured":"Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, S\u00f6rgel F (2009) Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet 48(2):89\u2013124","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1128_CR24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkn554","volume":"63","author":"KI Udekwu","year":"2009","unstructured":"Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR (2009) Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother 63(4):745\u2013757","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"1128_CR25","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1001\/jama.290.24.3207","volume":"290","author":"HR Vikram","year":"2003","unstructured":"Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ (2003) Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 290(24):3207\u20133214","journal-title":"JAMA"},{"issue":"3","key":"1128_CR26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jac\/47.3.357","volume":"47","author":"TR Walsh","year":"2001","unstructured":"Walsh TR, Howe RA, Wootton M, Bennett PM, MacGowan AP (2001) Detection of glycopeptide resistance in Staphylococcus aureus. J Antimicrob Chemother 47(3):357\u2013358","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1128_CR27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","volume":"40","author":"A Mangili","year":"2005","unstructured":"Mangili A, Bica I, Snydman DR, Hamer DH (2005) Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 40(7):1058\u20131060","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1128_CR28","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/JCM.43.10.5384-5387.2005","volume":"43","author":"HR Vikram","year":"2005","unstructured":"Vikram HR, Havill NL, Koeth LM, Boyce JM (2005) Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin. J Clin Microbiol 43(10):5384\u20135387","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1128_CR29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","volume":"44","author":"DJ Skiest","year":"2006","unstructured":"Skiest DJ (2006) Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 44(2):655\u2013656","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1128_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/502688","volume":"27","author":"D Hirschwerk","year":"2006","unstructured":"Hirschwerk D, Ginocchio CC, Bythrow M, Condon S (2006) Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 27(3):315\u2013317","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"1128_CR31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","volume":"44","author":"FM Marty","year":"2006","unstructured":"Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK (2006) Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 44(2):595\u2013597","journal-title":"J Clin Microbiol"},{"issue":"Pt 8","key":"1128_CR32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1099\/jmm.0.2008\/000588-0","volume":"57","author":"MH Murthy","year":"2008","unstructured":"Murthy MH, Olson ME, Wickert RW, Fey PD, Jalali Z (2008) Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol 57(Pt 8):1036\u20131038","journal-title":"J Med Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1128-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1128-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1128-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:34:22Z","timestamp":1559122462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1128-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1128-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,30]]}}}